Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double‐blind, placebo‐controlled study-Reference-Cited by-同舟云学术

Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double‐blind, placebo‐controlled study

Published:2016-04-15 Issue:3 Volume:41 Page:298-305
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Hosoya T.¹,Sasaki T.²,Hashimoto H.³,Sakamoto R.³,Ohashi T.²

Affiliation:

1. Department of Pathophysiology and Therapy in Chronic Kidney Disease Jikei University School of Medicine Tokyo Japan

2. Medical R&D Division Fuji Yakuhin Co., Ltd. Saitama Japan

3. Drug Development Center Sanwa Kagaku Kenkyusho Co., Ltd. Aichi Japan

Funder

Fuji Yakuhin Co., Ltd.

Sanwa Kagaku Kenkyusho Co., Ltd.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.12392

Reference26 articles.

1. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?;Li‐Yu J;J Rheumatol,2001

2. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: Evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy

3. Epidemiology of gout and hyperuricemia

4. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study

5. The impact of serum uric acid on cardiovascular outcomes in the LIFE study

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of 4‐(isopentyloxy)‐3‐nitrobenzamide derivatives as xanthine oxidase inhibitors through a non‐anthraquinone exploration;Archiv der Pharmazie;2024-07-04

2. Triazole derivatives as potential xanthine oxidase inhibitors: Design, enzyme inhibition potential, and docking studies;Archiv der Pharmazie;2024-01-09

3. Agents for the Treatment of Gout: Current Advances and Future Perspectives;Journal of Medicinal Chemistry;2023-11-01

4. Synthesis, characterization, luminescence, and catalytic properties of a zinc(II) complex with a N,O-donor ligand generated in situ from topiroxostat;Zeitschrift für Naturforschung B;2023-06-22

5. Design, synthesis and structure-activity relationship of N-phenyl aromatic amide derivatives as novel xanthine oxidase inhibitors;Bioorganic Chemistry;2023-04